Perrigo Company PLC - Asset Resilience Ratio
Perrigo Company PLC (PRGO) has an Asset Resilience Ratio of 0.00% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See PRGO working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1998–2023)
This chart shows how Perrigo Company PLC's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Perrigo Company PLC asset portfolio.
Liquid Assets Composition Over Time
This chart breaks down Perrigo Company PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Perrigo Company PLC strategic investment ratio to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $100.00K | 0.0% |
| Total Liquid Assets | $100.00K | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Perrigo Company PLC maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Perrigo Company PLC Industry Peers by Asset Resilience Ratio
Compare Perrigo Company PLC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Beijing Tongrentang Co Ltd
SHG:600085 |
Drug Manufacturers - Specialty & Generic | 0.50% |
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Neuland Laboratories Limited
NSE:NEULANDLAB |
Drug Manufacturers - Specialty & Generic | 9.65% |
|
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062 |
Drug Manufacturers - Specialty & Generic | 1.18% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.01% |
Annual Asset Resilience Ratio for Perrigo Company PLC (1998–2023)
The table below shows the annual Asset Resilience Ratio data for Perrigo Company PLC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 0.00% | $100.00K | $10.81 Billion | +0.00pp |
| 2022-12-31 | 0.00% | $100.00K | $11.02 Billion | 0.00pp |
| 2021-12-31 | 0.00% | $400.00K | $10.43 Billion | -0.02pp |
| 2020-12-31 | 0.02% | $2.50 Million | $11.49 Billion | -0.04pp |
| 2019-12-31 | 0.06% | $6.60 Million | $11.30 Billion | -0.03pp |
| 2018-12-31 | 0.09% | $9.40 Million | $10.98 Billion | -0.06pp |
| 2017-12-31 | 0.15% | $17.00 Million | $11.63 Billion | -0.13pp |
| 2016-12-31 | 0.28% | $38.20 Million | $13.87 Billion | +0.21pp |
| 2015-12-31 | 0.07% | $12.70 Million | $19.39 Billion | +0.02pp |
| 2014-12-31 | 0.04% | $5.90 Million | $13.88 Billion | 0.00pp |
| 2013-12-31 | 0.04% | $6.00 Million | $13.85 Billion | -0.07pp |
| 2012-12-31 | 0.11% | $5.90 Million | $5.35 Billion | +0.09pp |
| 2009-12-31 | 0.02% | $557.00K | $3.09 Billion | +0.02pp |
| 2008-12-31 | 0.00% | $3.00K | $2.54 Billion | -0.02pp |
| 2007-12-31 | 0.02% | $560.00K | $2.58 Billion | -2.53pp |
| 2006-12-31 | 2.55% | $49.11 Million | $1.93 Billion | +1.02pp |
| 2005-12-31 | 1.53% | $26.73 Million | $1.75 Billion | +0.49pp |
| 2004-12-31 | 1.04% | $17.76 Million | $1.70 Billion | -0.33pp |
| 2003-12-31 | 1.38% | $10.45 Million | $759.09 Million | -13.94pp |
| 1998-12-31 | 15.32% | $89.10 Million | $581.70 Million | -- |
About Perrigo Company PLC
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and ora… Read more